Importance of high radiation doses (72 Gy or greater) in the treatment of Stage T1-T3 adenocarcinoma of the prostate

This publication has 16 references indexed in Scilit:

• IMPROVEMENT IN OVERALL SURVIVAL FOR PATIENTS WITH LOCALIZED PROSTATE CANCER WITH HIGHER THAN STANDARD RADIATION DOSES
  Journal of Urology, 1999
• Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directions
  International Journal of Radiation Oncology*Biology*Physics, 1998
• Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer
  International Journal of Radiation Oncology*Biology*Physics, 1998
• Androgen ablation in addition to radiation therapy for prostate cancer: Is there true benefit?
  Seminars in Radiation Oncology, 1998
• External beam radiotherapy for stage T1/T2 prostate cancer: how does it stack up?
  Urology, 1998
• External beam radiotherapy dose response of prostate cancer
  International Journal of Radiation Oncology*Biology*Physics, 1997
• Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin
  New England Journal of Medicine, 1997
• Indications for excluding the seminal vesicles when treating clinically localized prostatic adenocarcinoma with radiotherapy alone
  International Journal of Radiation Oncology*Biology*Physics, 1997
• Conventional vs. conformal radiotherapy for prostate cancer: Preliminary results of dosimetry and acute toxicity
  International Journal of Radiation Oncology*Biology*Physics, 1996
• Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the radiation therapy oncology group
  Urology, 1995